145 related articles for article (PubMed ID: 8562465)
1. Primary prevention in patients with coronary heart disease: the APSIS study.
Rehnqvist N; Hjemdahl P; Björkander I; Eriksson SV; Forslund L; Held C; Wallén H; Billing E
Cardiovasc Drugs Ther; 1995 Aug; 9 Suppl 3():493. PubMed ID: 8562465
[TBL] [Abstract][Full Text] [Related]
2. Effects of metoprolol vs verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS).
Rehnqvist N; Hjemdahl P; Billing E; Björkander I; Eriksson SV; Forslund L; Held C; Näsman P; Wallén NH
Eur Heart J; 1996 Jan; 17(1):76-81. PubMed ID: 8682134
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of results from exercise testing in patients with chronic stable angina pectoris treated with metoprolol or verapamil. A report from the Angina Prognosis Study In Stockholm (APSIS).
Forslund L; Hjemdahl P; Held C; Björkander I; Eriksson SV; Brodin U; Rehnqvist N
Eur Heart J; 2000 Jun; 21(11):901-10. PubMed ID: 10806014
[TBL] [Abstract][Full Text] [Related]
4. Prognostic implications of ambulatory myocardial ischemia and arrhythmias and relations to ischemia on exercise in chronic stable angina pectoris (the Angina Prognosis Study in Stockholm [APSIS]).
Forslund L; Hjemdahl P; Held C; Eriksson SV; Björkander I; Rehnqvist N
Am J Cardiol; 1999 Nov; 84(10):1151-7. PubMed ID: 10569322
[TBL] [Abstract][Full Text] [Related]
5. Favourable long term prognosis in stable angina pectoris: an extended follow up of the angina prognosis study in Stockholm (APSIS).
Hjemdahl P; Eriksson SV; Held C; Forslund L; Näsman P; Rehnqvist N
Heart; 2006 Feb; 92(2):177-82. PubMed ID: 15951393
[TBL] [Abstract][Full Text] [Related]
6. Fibrinolytic variables and cardiovascular prognosis in patients with stable angina pectoris treated with verapamil or metoprolol. Results from the Angina Prognosis study in Stockholm.
Held C; Hjemdahl P; Rehnqvist N; Wallén NH; Björkander I; Eriksson SV; Forslund L; Wiman B
Circulation; 1997 May; 95(10):2380-6. PubMed ID: 9170400
[TBL] [Abstract][Full Text] [Related]
7. Treatment of silent ischemia in unstable angina: a randomized comparison of sustained-release verapamil versus metoprolol.
Singh N; Mironov D; Goodman S; Morgan CD; Langer A
Clin Cardiol; 1995 Nov; 18(11):653-8. PubMed ID: 8590535
[TBL] [Abstract][Full Text] [Related]
8. [Calcium antagonists and primary prevention of coronary disease].
Rehnqvist N
Arch Mal Coeur Vaiss; 1995 Sep; 88 Spec No 4():13-6. PubMed ID: 7503620
[TBL] [Abstract][Full Text] [Related]
9. Prognostic implications of renal dysfunction in patients with stable angina pectoris.
Almquist T; Forslund L; Rehnqvist N; Hjemdahl P
J Intern Med; 2006 Dec; 260(6):537-44. PubMed ID: 17116004
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris. Results from the APSIS study. The Angina Prognosis Study in Stockholm.
Held C; Hjemdahl P; Håkan Wallén N; Björkander I; Forslund L; Wiman B; Rehnqvist N
Atherosclerosis; 2000 Jan; 148(1):179-88. PubMed ID: 10580184
[TBL] [Abstract][Full Text] [Related]
11. Treatment of stable angina pectoris with calcium antagonists and beta-blockers. The APSIS study. Angina Prognosis Study in Stockholm.
Rehnqvist N; Hjemdahl P; Billing E; Björkander I; Eriksson SV; Forslund L; Held C; Näsman P; Wallén HN
Cardiologia; 1995 Dec; 40(12 Suppl 1):301. PubMed ID: 8903053
[No Abstract] [Full Text] [Related]
12. Pharmacologic therapy of angina pectoris.
Zavecz JH; Bueno O
J La State Med Soc; 1995 May; 147(5):208-10, 213-6. PubMed ID: 7782675
[TBL] [Abstract][Full Text] [Related]
13. [Anti-angina therapy of coronary heart disease. Mono- or combination treatment].
Kurz T; Rauch B; Kübler W
Z Kardiol; 1991 May; 80(5):305-16. PubMed ID: 1678565
[TBL] [Abstract][Full Text] [Related]
14. [Beta receptor blockers and calcium antagonists in coronary disease. Differential therapeutic aspects].
Delius W
Dtsch Med Wochenschr; 1983 Jul; 108(30):1154-8. PubMed ID: 6140156
[No Abstract] [Full Text] [Related]
15. Angina pectoris and silent ischemia in the elderly: a management update.
Lazar EJ; Lazar JM; Frishman W
Geriatrics; 1992 Jul; 47(7):24-8, 35-6. PubMed ID: 1352266
[TBL] [Abstract][Full Text] [Related]
16. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O
Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
[TBL] [Abstract][Full Text] [Related]
17. [Drugs in secondary prevention of ischemic heart disease: achievements, problems and prospects].
Metelitsa VI
Kardiologiia; 1989 Nov; 29(11):57-62. PubMed ID: 2575683
[TBL] [Abstract][Full Text] [Related]
18. Calcium blockers in angina. How they work, when to prescribe.
Heupler FA
Postgrad Med; 1984 May; 75(6):127-32. PubMed ID: 6144093
[TBL] [Abstract][Full Text] [Related]
19. Rationale for treating angina pectoris in patients with heart failure.
Heikkilä J
Acta Med Scand Suppl; 1985; 694():166-77. PubMed ID: 2860772
[No Abstract] [Full Text] [Related]
20. Unstable angina pectoris.
Coyle JF; Basta LL
Geriatrics; 1983 Sep; 38(9):79-84, 89-92. PubMed ID: 6136452
[No Abstract] [Full Text] [Related]
[Next] [New Search]
